Можливості впровадження біоекономіки у фармацевтичні підприємства
This study examines the bioeconomy’s role in the pharmaceutical sector, emphasizing biotechnology’s impact and forecasts for biological products up to 2028. It highlights growth trends and significance, alongside employment and productivity metrics in 2015 and 2020. A case study on Gilead Sciences i...
Gespeichert in:
| Datum: | 2024 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | English |
| Veröffentlicht: |
Odesa National University of Technology
2024
|
| Online Zugang: | //journals.ontu.edu.ua/index.php/fie/article/view/2941 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Назва журналу: | Food Industry Economics |
Institution
Food Industry Economics| Zusammenfassung: | This study examines the bioeconomy’s role in the pharmaceutical sector, emphasizing biotechnology’s impact and forecasts for biological products up to 2028. It highlights growth trends and significance, alongside employment and productivity metrics in 2015 and 2020. A case study on Gilead Sciences illustrates how biotechnology influences its growth, and a flowchart outlines future bioeconomy development. The bioeconomy utilizes biological resources to create products that enhance environmental sustainability and human health. The dynamic pharmaceutical industry, focused on medication research and production, requires effective entrepreneurial coordination. Entrepreneurship is characterized by competitiveness, risk-taking, and market opportunities and intersects with bioeconomy and pharmaceuticals. It empowers pharmaceutical firms to develop eco-friendly, effective drugs and fosters collaboration essential for advancing biological innovations. By adopting bioeconomic principles, pharmaceutical companies can enhance public health and promote sustainable resource use. |
|---|